Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials

被引:15
作者
Bae, Jong-Myon [1 ]
机构
[1] Jeju Natl Univ, Sch Med, Dept Prevent Med, 102 Jejudaehak Ro, Jeju 63243, South Korea
关键词
Probiotics; Diarrhea; Randomized controlled trials; Meta-analysis; DOUBLE-BLIND; PREVENTION; LACTOBACILLI;
D O I
10.4178/epih.e2018043
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: The 2017 guideline for the prevention of travelers' diarrhea (TD) by the International Society of Travel Medicine suggested that 'there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat TD.' However, a meta-analysis published in 2007 reported significant efficacy of probiotics in the prevention of TD (summary relative risk [sRR], 0.85, 95% confidence interval [CI], 0.79 to 0.91). This study aimed to synthesize the efficacy of probiotics on TD by updating the meta-analysis of double-blind, placebo-controlled, randomized human trials. METHODS: The search process was conducted by the adaptive meta-analysis method using the 'cited by' and 'similar articles' options provided by PubMed. The inclusion criteria were double-blind, placebo-controlled, randomized human trials with hypotheses of probiotics as intervention and TD as an outcome. The adaptive meta-analysis was conducted using Stata software using the csi, metan, metafunnel, and metabias options. RESULTS: Eleven articles were selected for the meta-analysis. The sRR was 0.85 (95% CI, 0.79 to 0.91) and showed statistical significance. There was no heterogeneity (I-squared=28.4%) and no publication bias. CONCLUSIONS: Probiotics showed statistically significant efficacy in the prevention of TD.
引用
收藏
页数:4
相关论文
共 20 条
[1]  
Bae Jong-Myon, 2016, J Prev Med Public Health, V49, P129, DOI 10.3961/jpmph.15.074
[2]  
Black F., 1989, TRAVEL MED C INT TRA, P333
[3]   Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of Traveler's diarrhea:: A randomized, double-blind, controlled study [J].
Briand, Valerie ;
Buffet, Pierre ;
Genty, Sabine ;
Lacombe, Karine ;
Godineau, Nadine ;
Salomon, Jerome ;
Vandemelbrouck, Eric ;
Ralaimazava, Pascal ;
Goujon, Catherine ;
Matheron, Sophie ;
Fontanet, Arnaud ;
Bouchaud, Olivier .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) :1170-1175
[4]   A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea [J].
Drakoularakou, A. ;
Tzortzis, G. ;
Rastall, R. A. ;
Gibson, G. R. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2010, 64 (02) :146-152
[5]   Epidemiology, etiology and pathophysiology of Traveler's diarrhea [J].
Gascón, J .
DIGESTION, 2006, 73 :102-108
[6]   Can a galacto-oligosaccharide reduce the risk of traveller's diarrhoea? A placebo-controlled, randomized, double-blind study [J].
Hasle, Gunnar ;
Raastad, Ragnhild ;
Bjune, Gunnar ;
Jenum, Pal A. ;
Heier, Lise .
JOURNAL OF TRAVEL MEDICINE, 2017, 24 (05)
[7]  
Hilton, 1997, J Travel Med, V4, P41, DOI 10.1111/j.1708-8305.1997.tb00772.x
[8]   LACTOBACILLI TO PREVENT TRAVELERS DIARRHEA [J].
KATELARIS, PH ;
SALAM, I ;
FARTHING, MJG .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1360-1361
[9]  
Kollaritsch H, 1993, Fortschr Med, V111, P152
[10]  
Kollaritsch H, 1989, Travel Medicine International, V6, P9